Current smokers with colon cancer are 14-21% more likely to die within five years compared to never smokers. Smoking prevention and cessation efforts may improve survival rates from colon cancer.
Researchers have identified B0AT1 inhibitors as a potential replacement for gastric bypass surgery in treating obesity and related disorders. These compounds, including benztropine, could replicate the effects of gastric bypass by reducing nutrient absorption, offering a new treatment option.
Researchers found that inhibiting intestinal protein NCoR1 breaks down bilirubin, eliminating signs of severe neonatal hyperbilirubinemia in mice. This discovery could lead to new therapeutic approaches for preventing or treating the condition.
A recent study published in Alimentary Pharmacology & Therapeutics found that the 10-year incidence of liver cancer in UK patients with cirrhosis is as low as 4%. Patients with cirrhosis due to chronic viral hepatitis have the highest risk, but even then, it's lower than expected.
A systematic review found that both endovascular (EVAR) and open surgical (OSR) repairs for abdominal aortic aneurysm (AAA) can lead to renal function impairment. The study included six studies with over 2,100 patients, revealing similar risks of renal decline in EVAR and OSR groups.
Pre-operative liquid feeding is associated with reduced post-operative abscesses and intestinal leakage by nine-fold, with only one of 38 patients developing these complications. This study suggests exclusive enteral nutrition as a bridge to safer semi-elective surgery for complicated Crohn's disease patients.
A new study found that dietary supplements containing red yeast rice may carry both benefits and risks associated with statins. The beneficial effects of RYR are attributed to monacolins, which are chemically related to statins.
Scientists at Roswell Park Comprehensive Cancer Center have identified gatekeeper genes that allow prostate cancer to progress and resist treatment. The study highlights opportunities to prevent or reverse this process, offering new insights into lineage plasticity and its application in other types of cancers.
Commonly prescribed acid suppression medications were linked with increased risks of intestinal infections with C. difficile and Campylobacter bacteria. Users should be vigilant about food hygiene due to the removal of stomach acid making them more susceptible to infection.
UT Southwestern Medical Center researchers developed a nanosensor that amplifies pH signals in tumor cells, distinguishing them from normal cells. The sensor helps surgeons see tumors better during surgery, potentially improving survival and quality of life for cancer patients.
The review highlights the need for personalized biologic dosing in rheumatoid arthritis treatment due to varying patient responses and drug concentrations. Implementing individualized doses can improve therapeutic outcomes while reducing costs.
A study of over 105,000 light and heavy social drinkers found a variation in the β-Klotho gene associated with decreased desire for alcohol. The less frequent variant is seen in approximately 40% of participants and is linked to a reduced risk of excessive drinking.
The University of Utah Health has received a five-year contract renewal from the NIH to test drugs for treating refractory epilepsy, with the goal of identifying novel compounds. The program aims to address unmet medical needs in epilepsy patients and develop new therapies for different types of epilepsy.
A recent study found that low-fat diets and regular exercise can reduce liver inflammation and scarring in patients with non-alcoholic steatohepatitis. Additionally, improved liver health was associated with enhanced kidney function in these individuals, independent of other factors such as diabetes or weight loss.
A review of studies found that most patients were unaware of reporting systems and others were confused about reporting. Patients who did report adverse reactions cited motivations for preventing similar suffering in others.
A new synthetic binding protein called NS1 monobody has been developed to block the activity of genetic mutations found in nearly 90% of pancreatic cancers. This breakthrough discovery provides insight into how RAS proteins function in cells, potentially leading to new therapeutic approaches for treating cancer.
A new analysis of 1981 patients with lower gastrointestinal symptoms found that the new criteria would miss nearly 20% of colorectal cancers. The study suggests that alarm features indicative of colorectal cancer are common among the general population, limiting their accuracy in predicting a diagnosis.
Researchers have discovered that SLC6A14 is overexpressed in pancreatic tumors and cancerous cells, transporting amino acids for cellular metabolism. Blocking SLC6A14 with alpha-methyltryptophan starves pancreatic cancer cells, reducing growth and proliferation
Researchers develop artificial cell-like spheres from natural proteins to study drug transport and variability. Variants in genes ABCB1 and CYP19A1 associated with anastrozole concentrations and joint pain in breast cancer patients.
A study of 1000 adult patients in Singapore found that gastrointestinal-related ADRs were common, while cardiovascular drugs caused the majority. Patients with ADRs had a longer hospital stay, suggesting some ADRs may be predictable based on genetics.
Researchers found that ibuprofen arginate is better tolerated, released more rapidly into the bloodstream, and provides faster pain relief compared to current formulations. This new formulation may negate cardiovascular side effects associated with high doses of ibuprofen.
Researchers explore using human pluripotent stem cells to identify cardiotoxicity risks in patients taking chemotherapy agents and other drugs. This approach may boost the number of successful clinical trials for cardiovascular disease treatments.
Researchers found that exercise and methamphetamine can re-establish circadian rhythmicity in animals, suggesting a potential new way to treat addiction. This approach associates drug usage with a non-harmful stimulus, leveraging brain plasticity to rewiring the brain's circuitry.
Researchers are working to develop safer drug treatments for newborns through increased clinical trials and improved efficiency. Currently, most medication treatments in newborns are based on adult studies, which can lead to uncertainty about their effectiveness.
A new review found that certain alternative therapies, such as probiotics and fiber, are effective in treating IBS symptoms. Patients with functional constipation and ulcerative colitis may also benefit from synbiotics and Escherichia coli strain Nissle 1917.
A new study reveals that spontaneous reports of adverse drug reactions in newborns and infants are insufficient, highlighting the need for additional reporting strategies. The UK's Yellow Card Scheme, established over 50 years ago, has improved drug safety but may not be enough to capture all instances of adverse reactions.
New research points to relaxin-3 as a potential treatment target for mental illnesses like depression and anxiety. Developments in peptide technology could lead to selectively targeting RXFP3 to develop new class of drugs.
The study found that calcium channel blockers like verapamil and amlodipine work differently to treat heart arrhythmias and hypertension. Verapamil physically blocks pores to restore normal heart rhythm, while amlodipine indirectly prevents pore opening, relaxing blood vessels without affecting the heart.
A significant number of patients on clopidogrel therapy are also prescribed proton pump inhibitors (PPIs) omeprazole or esomeprazole, increasing the risk of cardiovascular events. Despite regulatory warnings, many physicians have continued to prescribe this combination.
A new review explores potential antioxidant approaches for Alzheimer's, Parkinson's, and other neurodegenerative diseases. Certain compounds targeting oxidative stress pathways, such as Nrf2, are being investigated.
Researchers found that adding anti-PCSK9 antibodies to existing treatments can significantly reduce LDL cholesterol levels in patients. The studies demonstrated a reduction in LDL cholesterol and achieved high response rates for both alirocumab and evolocumab.
A new study found that immunosuppressive drugs can alter visual performance in rats, which are commonly used for translational stem cell research. The findings have important implications for interpreting results of studies using these models.
A study found a distinct brain-to-gut pathway where psychological symptoms begin first, while another pathway links gut symptoms to mental health. Higher anxiety and depression levels predicted IBS development within a year.
Researchers identified ASCL1 as an essential protein in the development of small cell lung cancer, and deleting it in mice prevented cancer formation. The study highlights a new potential target for treatment, offering hope for improving survival rates for patients with this devastating disease.
A new systematic review found that gliclazide confers the lowest risk of hypoglycemia when added to metformin. This suggests prescribing a medication with a lower risk of low blood sugar may be a rational and affordable alternative for patients with type 2 diabetes.
Antioxidant supplements have been linked to cardiovascular disease, cancer, diabetes, and other conditions due to their impact on oxygen radicals. However, the review suggests that targeting specific sources of oxygen molecules may be a more effective approach.
A new study suggests that eating low-FODMAP rye bread may help alleviate IBS symptoms. Patients with irritable bowel syndrome can benefit from increasing their fiber intake through modified foods like rye bread.
Researchers at the Buck Institute discovered a small molecule that tricks C. elegans into a state of caloric restriction, extending its lifespan by 50%. This study suggests that primary sensory pathways represent new targets for human pharmacology to mimic the positive effects of a Spartan diet.
Researchers have developed a new method to grow blood vessels in a 3D scaffold, reducing transplant rejection risks and increasing tissue integration. The technique uses human platelet lysate gel and endothelial progenitor cells, paving the way for fully vascularized tissues or organs.
Researchers designed a helix-shaped supercrystal composed of quantum dots to separate organic molecules and enhance drug synthesis. The chirality of the supercrystal allows for accurate detection of chiral biomolecules, enabling precise identification of enantiomers in pharmaceuticals.
The University at Buffalo has partnered with the University of Zimbabwe to launch a five-year HIV research training program, supported by a $1.3 million NIH grant. The program aims to train future HIV researchers and address issues such as maternal-fetal transmission, resistance, and co-infection in Zimbabwe.
A retrospective analysis suggests that regular laxative use can stabilize Parkinson's disease rigidity, pointing to potential modifications in underlying disease processes. Further research is planned to confirm the mechanisms involved.
A review of nine observational studies found antipsychotic drug users nearly twice as likely to experience a heart attack as non-users. Patients with schizophrenia and those taking the drugs for less than 30 days had even higher risks.
Researchers have identified gene variants associated with a serious adverse reaction to antithyroid drugs used for hyperthyroidism treatment. The study found that certain immune genes increase the risk of agranulocytosis, a life-threatening condition.
Luis Martinez, a PhD candidate at the University of Houston College of Pharmacy, has made significant breakthroughs in understanding Fragile X Syndrome. His research suggests that pharmacologically inhibiting Rac1 can rescue cognitive deficits and improve learning and memory skills in FXS models.
Researchers at Joslin Diabetes Center have identified the role of natural killer cells in abdominal fat inflammation and insulin resistance. By modulating NK cell activity, they found that inflammation in abdominal fat is suppressed and insulin resistance improves.
Baylor College of Medicine researchers have developed a new mathematical tool that combines biochemistry and computational analysis to identify specific structural changes in the dopamine 2 receptor, which helps maintain its structure and function throughout an evolutionary time scale. This discovery opens the possibility for better dr...
Researchers have identified a new target for treating asthma, finding that nociceptin reduces both immune response and airway constriction. This discovery offers a potential new approach to preventing or reducing established asthma attacks.
A spider toxin analogue, PnPP-19, has shown promise in relieving pain by targeting nervous system receptors similar to opioids and cannabis. The compound is also being studied for erectile dysfunction treatment.
Researchers identified 12 classes of drugs and 4 main mechanisms that can cause small arteries to constrict in response to cold, limiting blood supply. A recent study published in British Journal of Clinical Pharmacology highlights the need for further investigation into this condition.
A recent phase II clinical trial found that prucalopride significantly reduces the duration of intestinal paralysis after abdominal surgery. In the study, patients taking prucalopride experienced a reduced risk of prolonged ileus compared to those receiving a placebo.
During sleep, brain activity patterns from the day are replayed at fast-forward speed in the hippocampus, strengthening microscopic connections between nerve cells. This process is crucial for consolidating memories and retaining important information.
Researchers found that digoxin decreased levels of total cholesterol and triglycerides by 41% and 54%, respectively, in mice treated with high-dose digoxin. Digoxin also lowered LDL-cholesterol levels by 20%. The study suggests a potential link between the drug and reduced plaque buildup.
Researchers discovered that Rac1 activates a cascade of reactions in nerve cells associated with inflammatory pain. Inhibiting Rac1 using NSC23766 reduced pain hypersensitivity in rats injected with bee venom. These findings suggest potential for new drugs to treat chronic inflammatory pain.
Dasatinib, a cancer treatment, reduces inflammation and improves lung mechanics in mice with allergic asthma. The drug targets tyrosine kinases involved in asthma's signaling pathways.
The Concise Guide to PHARMACOLOGY 2015/2016 provides an overview of 1,700 human drug targets, focusing on those exploited in the clinic or with future therapeutic potential. The guide combines evidence-based data with summaries of molecular targets, allowing users to rapidly gain insight into their function and comparative pharmacology.
Researchers at UT Southwestern Medical Center discovered that fibroblast growth factor 21 (FGF21) reduces preference for sweets and alcohol in mammals by affecting the brain's reward pathway. FGF21 levels are associated with environmental stress, such as extreme dietary changes or cold temperature exposure.
Researchers assessed the impact of evidence-based principles on medicine procurement in a healthcare facility, achieving significant decreases in expenditures. The ABC/VEN-analysis method helped prioritize medicines and inform training workshops for medical professionals.
Researchers at UCLA have found a new way to reduce painful ascites, a common condition in ovarian cancer patients. The experimental drug inhibits macrophages, immune cells that help cancer spread, making the abdominal cavity less conducive to tumor growth.
A new mouse study reveals that high-fat diets can lead to anxiety and depressive symptoms, as well as measurable brain changes. The study also found that completely reversing the diet improved metabolic impairments and reduced anxious symptoms.